Millions of people are using GLP-1 drugs. Millions more are coming off them. Tens of millions are watching from the sidelines: wanting to lose weight, but unable to afford hefty
GLP-1 agonists have rewritten the rules of weight management almost overnight—and in the process created one of the biggest nutrition challenges (and opportunities) formulators have seen in decades.
For brands paying